Arcturus Therapeutics Holdings Inc (NAS:ARCT)
$ 18.36 -0.47 (-2.5%) Market Cap: 497.32 Mil Enterprise Value: 302.30 Mil PE Ratio: 0 PB Ratio: 1.90 GF Score: 76/100

Q4 2023 Arcturus Therapeutics Holdings Inc Earnings Call Transcript

Mar 07, 2024 / 09:30PM GMT
Release Date Price: $37.19 (-1.56%)
Operator

Greetings, and welcome to Arcturus Therapeutics Fourth Quarter and Full Year 2023 conference call. At this time, all participants are in a listen only mode. A question and answer session will follow the formal presentation. (Operator Instructions) As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Neda Safarzadeh, Vice President, Head of Investor Relations, Public Relations and Marketing. Thank you. You may now begin.

Neda Safarzadeh
Arcturus Therapeutics Holdings, Inc. - VP of IR, Public Relations, and Marketing

Thank you, operator. Good afternoon, and welcome to Arcturus Therapeutics quarterly financial update and pipeline progress call. today's call will be led by Joe Payne, our President and CEO; and Andrew Sassine, our CFO, Padmanabh Chivukula, our CSO and COO, will join them for the Q&A session. Before we begin, I would like to remind everyone that the statements made during this call regarding matters that are not historical facts are forward-looking statements within the Safe Harbor

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot